Heart & blood pressure · Jacksonville area, FL
Heart and blood pressure studies in Jacksonville area, FL
48 recruiting studies have a site in the Jacksonville area. This page includes nearby cities such as Orange Park, Jacksonville Beach, Ponte Vedra Beach, St. Augustine.
48 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Eli Lilly and Company
- Location
- Boca Raton, FL + 120 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
CRISPR Therapeutics AG
- Location
- Hialeah, FL + 7 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Amgen
- Location
- Altamonte Springs, FL + 117 other US sites
- Eligibility basics
- Ages 18–99
- Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Medtronic Cardiovascular
- Location
- Atlantis, FL + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Verve Therapeutics, Inc.
- Location
- Boca Raton, FL + 9 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
AstraZeneca
- Location
- Inverness, FL + 5 other US sites
- Eligibility basics
- Ages 18–70
- RecruitingPhase 3
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
AstraZeneca
- Location
- Clearwater, FL + 206 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Amgen
- Location
- Boca Raton, FL + 193 other US sites
- Eligibility basics
- Ages 50–105
- RecruitingPhase 3
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Novo Nordisk A/S
- Location
- Clearwater, FL + 129 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Alleviant ALLAY-HF Study
Alleviant Medical, Inc.
- Location
- Gainesville, FL + 42 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Eidos Therapeutics, a BridgeBio company
- Location
- Jacksonville, FL + 39 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
Novartis Pharmaceuticals
- Location
- Boca Raton, FL + 26 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Arga Medtech SA
- Location
- Jacksonville, FL + 17 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Altamonte Springs, FL + 131 other US sites
- Eligibility basics
- Ages 65+
- RecruitingPhase 2/Phase 3
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Kardigan, Inc.
- Location
- Atlantis, FL + 46 other US sites
- Eligibility basics
- Ages 50+
- RecruitingPhase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
DalCor Pharmaceuticals
- Location
- Clearwater, FL + 112 other US sites
- Eligibility basics
- Ages 45+
- RecruitingPhase 3
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Amgen
- Location
- Jacksonville, FL + 5 other US sites
- Eligibility basics
- Ages 35–80
- RecruitingPhase 3
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Intellia Therapeutics
- Location
- Jacksonville, FL + 36 other US sites
- Eligibility basics
- Ages 18–90
- Recruiting
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Vektor Medical
- Location
- Clearwater, FL + 9 other US sites
- Eligibility basics
- Ages 22+
- Recruiting
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Edwards Lifesciences
- Location
- Jacksonville, FL + 49 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
Kardion Inc
- Location
- Jacksonville, FL + 16 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingHealthy volunteersPhase 4
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Duke University
- Location
- Bay Pines, FL + 88 other US sites
- Eligibility basics
- Ages 75+
- RecruitingHealthy volunteers
Ultrasound With Subharmonic Imaging and Subharmonic Aided Pressure Estimation (SHAPE) to Identify Portal Hypertension
Mayo Clinic
- Location
- Jacksonville, FL + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 4
Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI
University of Florida
- Location
- Jacksonville, FL
- Eligibility basics
- Ages 18+
Who these studies look for
Many require a diagnosis or specific lab values such as LDL cholesterol or blood pressure readings, and exclude recent heart events.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.